Xos director files notice to sell 20,000 shares
The filing says 20,000 Xos shares are to be sold via UBS for about $60,000, tied to RSU vestings in June 2025 and June 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xos, Inc. (XOS) is the issuer for which director Dietmar Ostermann has filed a notice of proposed sale of securities under Rule 144. The notice covers up to 20,000 shares of common stock, to be sold through UBS Financial Services Inc., with an aggregate market value of $60,000. Shares of Xos common stock outstanding were 13,718,819 as of September 2, 2026; this is a baseline figure, not the amount being offered. The planned sales relate to RSU vestings of 7,216 shares on June 23, 2025 and 12,784 shares on June 22, 2026. In the prior three months, Ostermann reported several sales, including 10,000 shares on August 20, 2026 for $34,913 and a series of smaller transactions between July 10 and July 17, 2026.
Key Figures
Key Terms
Rule 144 regulatory
RSU Vesting financial
attorney-in-fact regulatory
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.